Successful pregnancy outcome following fertility-sparing treatment for cervical cancer: A case report on the challenges of assisted reproductive techniques.

Taiwan J Obstet GynecolSep 1, 2026

Hsiao-Han Chu, Tian-Chi Tsai, Liang-Hsuan Chen et al.

✦ AI-curated · Sources linked

Case in brief

A 37-year-old woman with stage IB cervical cancer underwent fertility-sparing treatment, including trachelectomy, radiotherapy, and chemotherapy. After cryopreserving oocytes and embryos, she faced initial embryo transfer failure due to cervical deformities and a thin endometrium. Following hormone replacement therapy and hysteroscopic correction, she achieved a successful singleton pregnancy, delivered via cesarean section at 29 weeks due to pre-eclampsia.

Diagnostic / clinical pearl

Clinicians should consider individualized assisted reproductive techniques for cervical cancer patients post-fertility-sparing treatment, as successful pregnancies can occur despite significant complications.

Why it matters

This case underscores the importance of addressing specific reproductive challenges in cancer survivors, highlighting the potential for successful outcomes with tailored interventions.

Source

Published in Taiwan J Obstet Gynecol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Obstetrics & Gynecology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.